HDAC inhibitors decrease mogamulizumab efficacy with downregulation of CCR4 in T-cell lymphomaAkihiro Kitadate,Sho Ikeda,Fumito Abe,Kazuaki Teshima,Naoto Takahashi,Kosei Matsue,Hiroyuki TagawaCANCER SCIENCE(2018)引用 0|浏览6暂无评分关键词Malignant lymphoma,HDAC inhibitorAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要